I-125 CE Marked QuickLink Cartridges — Class II medical device recall Z-0267-2018
Terminated recall by C.R. Bard, Inc., reported 2017-12-27. Activity and quantity of seeds sent in shipments were incorrect.
| Recall number | Z-0267-2018 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | C.R. Bard, Inc., Covington, GA, United States |
| Recall initiated | 2016-12-09 |
| Classified | 2017-12-20 |
| Reported by FDA | 2017-12-27 |
| Terminated | 2020-04-24 |
| Countries outside the US | BE, ZA |
| Quantity | 134 seeds |
| Lot numbers | BBAY0071, BBAY0072, BBAY0073, BBAY0079, BBAY0090 |
Product
I-125 CE Marked QuickLink Cartridges; Sterile; Bard Brachysource Radioactive Seeds in QuickLink Cartridges Indicated for permanent interstitial treatment of selected localized tumors such as: head and neck, lung, pancreas, and early stage prostate. Implants are indicated to treat residual tumors following completion of a course of external radiation therapy and for recurrent tumors.
Reason for recall
Activity and quantity of seeds sent in shipments were incorrect.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0267-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.